Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia
NCT ID: NCT07256145
Last Updated: 2025-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-08-01
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erector Spinae Plane Block in Post-herpetic Neuralgia
NCT04546334
Erector Spinae Block Versus Thoracic Paravertebral Block for Acute Thoracic Herpes Zoster
NCT04656821
The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia.
NCT07000409
Ultrasound Guided Serratus Anterior Versus Erector Spinae Block in Pain Alleviation in Acute Herpes Zoster
NCT06476080
Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia
NCT06761924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients will be evaluated by:
* Full history taking: including age, sex, presence of co-morbid conditions as well as the presenting complaint.
* Clinical examination and routine lab investigations that include:
* Complete blood count (CBC).
* Fasting blood glucose (FBG).
* Coagulation profile (bleeding time, prothrombin time, prothrombin activity, international normalized ratio).
Measurements:
Patients will be followed up at 24 hours, 1 week, and 6 weeks after injection.
The following measurements will be recorded:
1. Pain will be assessed pre- and post-injection using VAS score at 24 hours, 1 week, and 6 weeks post-injection.
2. Need for analgesic intake post-injection will be assessed at the follow-up periods.
3. Patient satisfaction using the SAPS score.
4. Complications post-injection as pain, irritation or infection will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Injection group
erector spinae plane block
erector spinae plane block with steroids
conventional group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
erector spinae plane block
erector spinae plane block with steroids
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
5- Immunocompromised patients, severe osteoporosis, and uncontrolled diabetes mellitus.
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alexandria University
Alexandria, Aleexandria, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0307429
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.